MOLECULAR MEDICINE
·
2025
·
IF 6.4
Quanpeng Qiu,Yi Ding,Xiaolong Guo,Jing Han,Jiaqi Zhang,Yaping Liu,Junjun She,Yinnan Chen
Background Extrachromosomal circular DNA (eccDNA) has potential in tumor diagnosis, particularly for improving diagnostic accuracy and early cancer detection; however, many challenges remain in its application to clinical practice. Methods We conducted a Circle‐Seq analysis on clinical samples at different stages of colorectal cancer progression to examine the dynamic changes of eccDNA during the progression of colorectal cancer. We used breakpoint-specific PCR to verify candidate eccDNAs identified by Circle‐Seq. The results were further validated using the AOM/DSS-induced colorectal cancer model. Results There was an increase in the abundance of eccDNA with the progression of colorectal cancer. The genes associated with these eccDNA molecules were primarily related to signaling pathways involved in tumor development and metastasis. Our analysis also revealed that eccDNA abundance positively correlates with gene expression, and eccDNA derived from specific genes has potential value for the early diagnosis of tumors. Conclusions This study revealed a connection between eccDNA and colorectal cancer progression and highlights the clinical potential of eccDNA for the early diagnosis of colorectal cancer. Supplementary Information The online version contains supplementary material available at 10.1186/s10020-025-01164-y.
✓ 已验证
产品关联
DOI
PubMed
高影响因子
BMC Pulmonary Medicine
·
2025
·Vol. 25
·期 1
·1-13
·
IF 2.8
Huang Zhiheng,Li Liangxian,Zhang Bingxi,Yao Dong,Xiao Bo,Mo Biwen
Background Bronchial asthma, a chronic inflammatory airway disease, is characterized by airway remodeling, including thickening of the airway smooth muscle layer, primarily due to abnormal proliferation of airway smooth muscle cells (ASMCs). CBL0137 (Curaxin-137 hydrochloride), a histone chaperone facilitate chromatin transcription (FACT) inhibitor, has demonstrated anti-tumor properties, including inhibition of proliferation, promotion of apoptosis, and increased autophagy. However, its effects on ASMCs and airway remodeling remain unexplored. Methods Asthma models were established using ovalbumin (OVA) in female C57BL/6 J mice, with therapeutic interventions using CBL0137 and budesonide. Lung tissues were analyzed using Hematoxylin and eosin (H&E), PAS, Masson’s trichrome, and α-SMA immunofluorescence staining. ASMCs extracted from Sprague–Dawley rats were cultured in vitro experiments, with phenotypic changes assessed via flow cytometry. Gene and protein expressions were analyzed using RT-PCR and Western blotting. Results CBL0137 significantly reduced airway resistance, goblet cell proliferation, alveolar collagen deposition, and airway smooth muscle layer thickening in asthmatic mice. In vitro, CBL0137 inhibited ASMC proliferation and induced apoptosis, downregulating cyclin-B1, Cdc2, and Bcl-2 while upregulating caspase-3. Conclusions CBL0137 mitigates airway remodeling of asthmatic mice by modulating ASMC proliferation and apoptosis, presenting a potential therapeutic strategy for asthma treatment.
✓ 已验证
产品关联
DOI
PubMed
高影响因子
Nature Communications
·
2025
·Vol. 16
·期 1
·1-11
·
IF 15.7
Qian Hui,Wang Yuxuan,Zhou Xibin,Gu Tao,Wang Hui,Lyu Hao,Li Zhikai,Li Xiuxu,Zhou Huan,Guo Chengchen,Yuan Fajie,Wang Yajie
The UniProt database is a valuable resource for biocatalyst discovery, yet predicting enzymatic functions remains challenging, especially for low-similarity sequences. Identifying superior enzymes with enhanced catalytic properties is even harder. To overcome these challenges, we develop ESM-Ezy, an enzyme mining strategy leveraging the ESM-1b protein language model and similarity calculations in semantic space. Using ESM-Ezy, we identify novel multicopper oxidases (MCOs) with superior catalytic properties, achieving a 44% success rate in outperforming query enzymes (QEs) in at least one property, including catalytic efficiency, heat and organic solvent tolerance, and pH stability. Notably, 51% of the MCOs excel in environmental remediation applications, and some exhibited unique structural motifs and unique active centers enhancing their functions. Beyond MCOs, 40% of L-asparaginases identified show higher specific activity and catalytic efficiency than QEs. ESM-Ezy thus provides a promising approach for discovering high-performance biocatalysts with low sequence similarity, accelerating enzyme discovery for industrial applications.
✓ 已验证
产品关联
DOI
PubMed
高影响因子
Nature Communications
·
2025
·Vol. 16
·期 1
·1-12
·
IF 15.7
Lin Yan,Li Hui,Miao Xiaodong,Sun Yunayuan,Ren Hao,Yu Xifeng,Cui Wangyang,Wu Mingbo,Li Zhongtao
Direct electro-epoxidation of propylene (D-EOPO) with a membrane electrode assembly (MEA) system represents a sustainable approach for producing propylene oxide, which can reduce ohmic losses and simplify product separation. To address the challenges of selectivity and activity, we develop an Ag/V catalyst and integrate it into the “liquid-free” MEA reactor for continues D-EOPO. The V in the catalyst facilitates the formation of Ag-O active centers, thereby reducing the generation energy of *O radicals. Meanwhile, V doping also results in a downshift of the d -band center of the Ag sites. Consequently, the formation of the crucial intermediate (*OC 3 H 6 ) is significantly accelerated through the coupling *O with adsorbed propylene, thereby markedly improving propylene oxide (PO) production. The MEA reactor, integrated with the developed Ag/V catalyst, can maintain a stable production rate of PO at 227 μmol/h over a period of 78 hours. Thus, the “liquid-free” electro-epoxidation protocol developed here exhibits greater industrial applicability.
✓ 已验证
产品关联
DOI
PubMed
高影响因子
JOURNAL OF NANOBIOTECHNOLOGY
·
2025
·Vol. 23
·期 1
·1-19
·
IF 12.6
Song Zhengwei,Sun Quanwei,Yang Wenshuo,Li Yunlong,Hu Chaoyu,Chen Chen,Liu Kang,Shen Wei,Yang Ye,Yin Dengke
Background Prolonging the duration of photodynamic therapy (PDT) enhances the level of reactive oxygen species (ROS), thereby facilitating tumor ablation. However, our findings indicated that excessive ROS not only induces epithelial-mesenchymal transition (EMT) but also creates an immunosuppressive microenvironment in tumor, thereby triggering tumor metastasis. Methods We initially developed neutrophil membrane hybrid liposomes (NLs) that can specifically target inflamed tumor tissues following PDT. Then, we utilized NLs to encapsulate the antioxidant nanozyme FeGA and the antiplatelet drug Lysine Acetylsalicylate (LAS), resulting in the formulation NLASF. Results Experimental results demonstrated that FeGA effectively scavenges ROS, thereby reversing the immunosuppressive microenvironment induced by prolonged PDT. Furthermore, the incorporation of LAS effectively disrupts the interaction between tumor cells and platelets, mitigating tumor EMT and inhibiting hematogenous tumor metastasis. In a breast cancer mouse model, we observed that treatment with NLASF led to a near-complete suppression of tumor lung metastasis following the prolonged PDT. Additionally, the in vivo application of NLASF did not result in any blood toxicity or organ toxicity, highlighting its significant advantages over the free drugs group. Conclusions This study provides a novel approach to enhance the efficacy of PDT and successfully suppress PDT-mediated tumor metastasis.
✓ 已验证
产品关联
DOI
PubMed
高影响因子
CATALYSIS LETTERS
·
2025
·Vol. 155
·期 5
·1-14
·
IF 2.4
Wang Xiangke,Meng Xuan,Shi Li,Liu Naiwang,Wang Jiyu
In the tert-butyl removal reaction, solid acid catalysts have emerged as a preferred alternative to liquid acid catalysts due to their environmentally friendly advantages. Various zeolites, such as ZSM-5, MCM-41, USY, and H beta, as well as mesoporous materials, such as γ-Al 2 O 3 and active clay were employed for the first time to prepare m-cresol through the tert-butyl removal reaction of 4,6-di-tert-butyl-m-cresol (4,6-DBMC). γ-Al 2 O 3 and active clay catalysts were found to have excellent catalytic performance in this reaction. The thermodynamic properties of the tert-butyl removal reaction of 4,6-DBMC were studied. Under different temperature and solvent conditions, the product distribution was investigated. A proposed reaction pathway and mechanism were proposed. And through cyclic experiments, the stability of γ-Al 2 O 3 and active clay catalysts was investigated separately. After six cycles, the m-cresol yield for active clay catalyst was still maintained at about 90%. The causes of deactivation of the two catalysts were analyzed. After regeneration, both catalysts exhibited good regeneration performance. This study offers a basis for the selection of solid acid catalysts for the tert-butyl groups removal of 4,6-DBMC. Graphical abstract
✓ 已验证
产品关联
DOI
高影响因子
Microbial Cell Factories
·
2025
·Vol. 24
·期 1
·1-11
·
IF 4.9
Liu Wen,Guo Jing,Lu Wei,Cheng Tao,Li Yiting,Xian Mo,Zhang Rubing
Background L -5-Methyltetrahydrofolate (5-MTHF) is the sole biologically active form of folate present in human blood and serves as an essential nutritional supplement. While microbial biosynthesis of 5-MTHF offers a sustainable alternative to chemical synthesis, its low yield limits industrial potential. Results In this study, strategies for improving the methyl supply combined with engineering the tetrahydrofolate (THF) synthetic pathway were employed in E. coli to increase 5-MTHF production. First, a new exogenous C1 pathway was introduced to improve the intracellular methyl supply through acetyl-CoA breakdown. High expression of key rate-limiting genes folE , folP and purU enhanced metabolic flux of THF pathway, resulting in a 5-MTHF titer of 1.075 mg/L during shake-flask fermentation. A subsequent increase in 5-MTHF production was achieved by knocking out the metE gene, which is involved in the consumption of 5-MTHF. The best engineered strain, M3012, produced 8.2 mg/L 5-MTHF in a 5 L bioreactor via fed-batch fermentation, which presented the highest 5-MTHF titer to date. Conclusion We successfully engineered E. coli by introducing a novel exogenous C1 metabolic pathway to augment the methyl donor pool essential for the biosynthesis of 5-MTHF. Further metabolic optimizations, including the enhancement of the THF precursor flux and the elimination of competing degradation pathways, developed a recombinant strain with significantly increased yield, which paves the way for industrial production of 5-MTHF.
✓ 已验证
产品关联
DOI
PubMed
高影响因子
CATALYSIS LETTERS
·
2025
·Vol. 155
·期 5
·1-13
·
IF 2.4
Lu Xingyu,Sun Jiahao,Yang Pengfei,Yang Xianjun,Hu Qin,Chen Liuyun,Qin Zuzeng,Su Tongming
CdS photocatalysts have attracted extensive attention in the area of photocatalytic hydrogen generation, yet their limited light absorption and charge transfer efficiencies still restrict their photocatalytic performance. In this study, NiS was grown on CdS to synthesize xNiS/CdS composites via a hydrothermal method and was used for photocatalytic hydrogen evolution. The introduction of NiS increased the light absorption intensity and broadened the light absorption range in the visible light region. In addition, a close contact interface formed between NiS and CdS, which accelerated the transfer and separation of photogenerated electrons and holes. Furthermore, NiS acts as the electron aggregation center and active site for photocatalytic hydrogen evolution. Therefore, the photocatalytic performance of the xNiS/CdS composites was greatly enhanced. Among the xNiS/CdS composites, the 0.5NiS/CdS composite exhibited the optimal photocatalytic hydrogen evolution rate of 36.75 mmol·h − 1 ·g − 1 , which was 7.84 times greater than that of CdS. A possible mechanism of photocatalytic H 2 production over xNiS/CdS is also proposed. This work provides new inspiration for the rational design of high-efficiency cocatalyst/CdS composites. Graphical
✓ 已验证
产品关联
DOI
高影响因子
JOURNAL OF POROUS MATERIALS
·
2025
·
IF 3.2
Feng Yulin,Xu Fen,Sun Lixian,Shao Qiwei,Xu Rudan,Chen Yue,Yu Chuyu,Du Maozhan,Xie Yingguang
The interfacial chemical bonding strategy has been proposed by utilizing the expanded graphite (EG) as substrate to overcome the inherent low conductivity of covalent organic frameworks (COFs) in supercapacitor in this work. A redox-active COF material grows in situ on the EG surface through a solvent-free synthesis method, successfully constructing a novel layered porous EG@COF composite. Analysis results of BET, XPS and resistivity of materials demonstrate that the EG@COF not only preserves the intrinsic high specific surface area of COFs, but also effectively reduces interfacial contact resistance via amidation reaction, significantly enhancing charge transfer efficiency. Electrochemical studies reveal that the optimized EG@COF-3 electrode has a high specific capacitance of 501 F g − 1 at 1 A g − 1 , with 92.3% capacity retention after 10,000 cycles, demonstrating a good cycling stability. Furthermore, the assembled EG@COF//AC asymmetric supercapacitor achieves an energy density of 16.4 Wh kg − 1 at a power density of 806.0 W kg − 1 . This work provides an effective solution to improve the conductivity of COF materials.
✓ 已验证
产品关联
DOI
高影响因子
BREAST CANCER RESEARCH
·
2025
·Vol. 27
·期 1
·1-19
·
IF 5.6
Kong Linghui,Hu Song,Zhao Ying,Huang Yan,Xiang Xiaobing,Yu Yang,Mao Xiaochun,Xie Kangjie,Zhu Xiaoyan,Xu Pingbo
Background The mechanisms underpinning neoadjuvant chemotherapy-induced vascular endothelial injury in breast cancer remain elusive. Our study aims to demonstrate that Neutrophil Extracellular Traps (NETs) play a pivotal role in neoadjuvant chemotherapy-induced vascular endothelial injury in breast cancer, elucidating that chemotherapy-induced upregulation of Solute Carrier 11a1 (Slc11a1) modulates Reactive Oxygen Species (ROS) generation, which may be critical for NETs formation.Methods We investigated the impact of neoadjuvant chemotherapy for breast cancer on NETs formation and vascular endothelial injury by analyzing NETs dsDNA and serum markers in patients, cells, and chemotherapy mouse models. RNA sequencing of neutrophils from chemotherapy mouse models was performed to identify the potential NETs formation-associated gene Slc11a1, which was further validated through cellular and animal experiments by assessing Slc11a1 expression, intracellular ferrous ion content, and ROS levels. Knockdown of Slc11a1 in human neutrophils and mouse models were also performed to further confirm the phenotypic results.Results Our study revealed that plasma NETs formation and endothelial injury markers were significantly elevated in breast cancer patients undergoing docetaxel & carboplatin (TCb) neoadjuvant chemotherapy, compared to controls. In these patients, NETs formation was associated with the augmentation of endothelial injury markers. Chemotherapy mouse models demonstrated that TCb treatment markedly elevated NETs formation and endothelial injury, which can be mitigated by CI-amidine, a protein-arginine deiminase inhibitor. In human neutrophils, we demonstrated that the TCb chemotherapeutic agents (combination of docetaxel and carboplatin) induced the formation of NETs, which subsequently facilitated damage to human umbilical vein endothelial cells in vitro. RNA sequencing of mouse neutrophils identified Slc11a1 as a key NETs formation-related gene, which was upregulated by TCb chemotherapy in neutrophils, leading to increased intracellular ferrous ion content and ROS generation. Knockdown of Slc11a1 in human neutrophils and mouse models demonstrated its reversal effect on TCb-induced ferrous ion upregulation, ROS generation, and NETs formation.Conclusion sOur research underscores the capacity of TCb neoadjuvant chemotherapy in breast cancer to augment NETs formation in neutrophils through Slc11a1-mediated ROS generation, which is linked to vascular endothelial injury. Our study elucidates the potential mechanisms underlying perioperative vascular endothelial injury in breast cancer patients undergoing neoadjuvant chemotherapy, offering novel insights into perioperative therapeutic management strategies for these patients.
✓ 已验证
产品关联
DOI
PubMed
高影响因子
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
·
2024
·
IF 0
Liu Yucheng,Zhu Mengke,Ji Xinghu,Tan Zhiyou,He Zhike
The reverse osmosis (RO) technique has been extensively employed in the advanced treatment of industrial water and wastewater. However, this process results in the production of a significant quantity of reverse osmosis concentrate (ROC), which contains high levels of salinity and organic contaminants, thereby posing serious environmental problems. This study reported a two-stage precipitation process utilizing quicklime (CaO) and caustic soda (NaOH) in conjunction with air blowing (carbonation) for the removal of Ca 2+ and Mg 2+ from real brackish water ROC of factory. In stage I, the CaO precipitation-carbonation process was employed to eliminate the majority of Ca 2+ from the ROC, while leaving Mg 2+ virtually unaffected, yielding high-purity CaCO 3 precipitates. In stage II, the NaOH precipitation method was utilized to eliminate the remaining Ca 2+ and Mg 2+ from the ROC. It was demonstrated that under optimal conditions, the removal rates of Ca 2+ and Mg 2+ exceeded 97%. Finally, the characterization of precipitates demonstrated the generation of high-purity CaCO 3 precipitates in stage I, as well as the formation of CaCO 3 and Mg(OH) 2 precipitates in stage II. The results confirmed the feasibility of employing the two-stage precipitation with carbonation process to economically treat ROC and enable its reuse, offering valuable insights for the treatment of industrial wastewater.
✓ 已验证
DOI
PubMed
ARCHIVES OF PHARMACAL RESEARCH
·
2024
·
IF 6.9
Hu Wenjie,Wang Yujie,Yang Huiling,Zhang Leiming,Liu Bo,Ji Yunxia,Song Xiaodong,Lv Changjun,Zhang Songzi
Pulmonary fibrosis is a chronic and irreversible progressive lung disease caused by various factors, such as age and environmental pollution. With countries stepping into an aging society and the seriousness of environmental pollution caused by global industrialization, the incidence of pulmonary fibrosis is annually increasing. However, no effective drug is available for pulmonary fibrosis treatment. C-phycocyanin (C-PC), extracted from blue-green algae, has good water solubility and antioxidation. This study elucidated that C-PC reinforces autophagy to block pulmonary fibrogenesis by inhibiting long noncoding RNA (lncRNA) biogenesis in vivo and in vitro. Cleavage under targets and release using nuclease (CUT & RUN)-PCR, co-immunoprecipitation (Co-IP), and nuclear–cytoplasmic separation experiments clarified that C-PC blocked the nuclear translocation of activating transcription factor 3 (ATF3) to prevent the binding between ATF3 and transcription factor Smad3, thereby hindering lncIAPF transcription. Human antigen R (HuR) truncation experiment and RNA binding protein immunoprecipitation (RIP) were then performed to identify the binding domain with lncIAPF in the 244–322 aa of HuR. lncIAPF exerted its profibrogenic function through the binding protein HuR, a negative regulator of autophagy. In summary, C-PC promoted autophagy via down-regulating the lncIAPF–HuR-mediated signal pathway to alleviate pulmonary fibrosis, showing its potential as a drug for treating pulmonary fibrosis. Exploring how C-PC interacts with biological molecules will help us understand the mechanism of this drug and provide valuable target genes to design new drugs.
✓ 已验证
产品关联
DOI
PubMed
高影响因子
危险品化学品经营许可证（带存储）